Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.85 HKD | -0.48% | -5.44% | -0.24% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
Sales 2024 * | 677M 93.35M 729M | Sales 2025 * | 1.5B 207M 1.62B | Capitalization | 6.2B 855M 6.68B |
---|---|---|---|---|---|
Net income 2024 * | -646M -89.14M -696M | Net income 2025 * | -160M -22.08M -172M | EV / Sales 2024 * | 7.83 x |
Net cash position 2024 * | 901M 124M 971M | Net cash position 2025 * | 336M 46.37M 362M | EV / Sales 2025 * | 3.9 x |
P/E ratio 2024 * |
-9.47
x | P/E ratio 2025 * |
-38.4
x | Employees | 432 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.97% |
Latest transcript on Everest Medicines Limited
1 day | -0.48% | ||
1 week | -4.36% | ||
Current month | -5.44% | ||
1 month | -18.40% | ||
3 months | -17.43% | ||
6 months | +3.47% | ||
Current year | -0.24% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Qing Luo
CEO | Chief Executive Officer | 54 | 22-09-18 |
Ian Ying Woo
PSD | President | 51 | 18-11-30 |
Michael Berry
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Fan Li
BRD | Director/Board Member | 55 | 20-08-31 |
Honggang Feng
BRD | Director/Board Member | 59 | Feb. 08 |
Wei Fu
CHM | Chairman | 42 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.75% | 4 M€ | -27.92% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 114 M€ | +4.36% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 20.85 | -0.48% | 1,332,500 |
24-06-06 | 20.95 | -5.63% | 4,299,000 |
24-06-05 | 22.2 | +1.14% | 2,898,000 |
24-06-04 | 21.95 | +1.86% | 2,822,500 |
24-06-03 | 21.55 | -2.27% | 2,563,000 |
Delayed Quote Hong Kong S.E., June 07, 2024 at 04:09 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.24% | 859M | |
+0.82% | 93.19B | |
-1.32% | 39.62B | |
-12.88% | 33.78B | |
+64.77% | 26.82B | |
-16.31% | 15.35B | |
-5.78% | 13.13B | |
-11.38% | 11.6B | |
-49.84% | 10.26B | |
+5.24% | 9.43B |
- Stock Market
- Equities
- 1952 Stock